This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West

Savings Deadline Expires:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
March 18-21, 2025
San Diego Convention CenterSan Diego, CA, USA

Haibin Luo, PhD
Director of Downstream Process Development, BioPharmaceutical Development at AstraZeneca
Speaker

Profile

Dr. Haibin Luo severs as a director in the Pharmaceutical Development organization at AstraZeneca, specializing in downstream process development for novel biologics (such as inhaled biologics and T-cell engagers), protein characterization, and safety risk assessment for process-related impurities. He has 13-year experience in downstream process development for early-to-late-stage drugs and regulatory filings, as well as 2-year experience on CMC team leadership. He published more than 20 papers on protein purification and characterization. He earned his PhD in Drug Design & Development from Chinese Academy of Sciences in 2006.

Agenda Sessions

  • Development and evolution of downstream purification platform for inhalable biologics

    9:30am